Overview

Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metastatic Colorectal Cancer

Status:
NOT_YET_RECRUITING
Trial end date:
2031-12-31
Target enrollment:
Participant gender:
Summary
The main objective of this study is to identify the prognostic factors (clinico-biological) for the efficacy (overall survival) of fruquintinib in patients with metastatic colorectal cancer.
Phase:
NA
Details
Lead Sponsor:
Federation Francophone de Cancerologie Digestive
Treatments:
HMPL-013